In 2020, InsurTech investment reached an all-time high of $7.1 billion with over 370 deals (WTW Q4 Report). The trend of increasing investment continued even during one of the darkest periods for insurers who were facing Covid liability, record natural disasters, and low interest rates.
While this number is significant, it still pales in comparison to the overall FinTech investment of $106 billion in 2020 (KMPG Pulse of FinTech). While investment increased, 2020 was a breakout year for InsurTechs to join the public markets. Lemonade, Root, Clover Health, Hippo, Metromile, and States Title, and others went public through the traditional process or Special Purpose Acquisitions Companies (SPACs). Early VCs and Corporate VCs realized 10x+ returns on many of these companies.
With the red-hot market, the question remains for many insurers and venture capitalists, how can they start investing in InsurTechs or support their existing portfolios. This event will explore early-stage, growth-stage, and mature InsurTech investing. It will also include networking opportunities with influential InsurTech investors.